tradingkey.logo
tradingkey.logo
Suchen

CeriBell Inc

CBLL
Zur Watchlist hinzufügen
16.300USD
-0.160-0.97%
Handelsschluss 05/15, 16:00ETKurse um 15 Minuten verzögert
618.47MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über CeriBell Inc Unternehmen

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.

CeriBell Inc Informationen

BörsenkürzelCBLL
Name des UnternehmensCeribell Inc
IPO-datumOct 11, 2024
CEOChao (Xingjuan)
Anzahl der mitarbeiter281
WertpapierartOrdinary Share
GeschäftsjahresendeOct 11
Addresse360 N. Pastoria Avenue
StadtSUNNYVALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94085
Telefon18004360826
Websitehttps://ceribell.com/
BörsenkürzelCBLL
IPO-datumOct 11, 2024
CEOChao (Xingjuan)

Führungskräfte von CeriBell Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.00M
-4.56%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-1.34%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
145.67K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
97.23K
+10.33%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Dr. Lucian Iancovici, M.D.
Dr. Lucian Iancovici, M.D.
Independent Director
Independent Director
--
--
Mr. Joseph M. Taylor
Mr. Joseph M. Taylor
Independent Director
Independent Director
--
--
Joseph Manni
Joseph Manni
Chief Revenue Officer
Chief Revenue Officer
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Josef Parvizi, M.D., Ph.D.
Dr. Josef Parvizi, M.D., Ph.D.
Director, Co-Founder
Director, Co-Founder
2.00M
-4.56%
Ms. Xingjuan (Jane) Chao, Ph.D.
Ms. Xingjuan (Jane) Chao, Ph.D.
President, Chief Executive Officer, Director, Co-Founder
President, Chief Executive Officer, Director, Co-Founder
1.05M
-1.34%
Dr. Raymond Woo, Ph.D.
Dr. Raymond Woo, Ph.D.
Chief Technology Officer
Chief Technology Officer
145.67K
--
Mr. Scott Blumberg
Mr. Scott Blumberg
Chief Financial Officer
Chief Financial Officer
97.23K
+10.33%
Mr. William W. (Bill) Burke
Mr. William W. (Bill) Burke
Independent Director
Independent Director
17.39K
--
Ms. Rebecca B. (Beckie) Robertson
Ms. Rebecca B. (Beckie) Robertson
Independent Chairman of the Board
Independent Chairman of the Board
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2022
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
EEG recorders and EEG headbands, point in time
67.33M
75.60%
EEG portal and Clarity subscriptions, over time
21.73M
24.40%
Nach RegionUSD
Name
Umsatz
Anteil
United States
89.06M
100.00%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
EEG recorders and EEG headbands, point in time
67.33M
75.60%
EEG portal and Clarity subscriptions, over time
21.73M
24.40%

Aktionärsstatistik

Aktualisiert: Sun, May 10
Aktualisiert: Sun, May 10
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
TPG Capital, L.P.
10.46%
Fidelity Management & Research Company LLC
10.00%
Longitude Capital Management Co., LLC
6.52%
Global Value Investment Portfolio Management Pte. Ltd.
6.24%
Red Tree Management, LLC
5.81%
Andere
60.96%
Aktionäre
Aktionäre
Anteil
TPG Capital, L.P.
10.46%
Fidelity Management & Research Company LLC
10.00%
Longitude Capital Management Co., LLC
6.52%
Global Value Investment Portfolio Management Pte. Ltd.
6.24%
Red Tree Management, LLC
5.81%
Andere
60.96%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
38.59%
Investment Advisor/Hedge Fund
19.97%
Private Equity
10.48%
Individual Investor
9.11%
Venture Capital
6.54%
Hedge Fund
5.18%
Research Firm
2.83%
Corporation
2.64%
Pension Fund
0.53%
Andere
4.13%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
236
31.90M
84.99%
-1.64M
2025Q4
202
30.92M
84.91%
-28.12K
2025Q3
202
30.95M
85.03%
-25.06K
2025Q2
178
30.95M
75.12%
+1.98M
2025Q1
151
30.66M
70.71%
+5.27M
2024Q4
110
29.39M
58.97%
+8.25M

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
TPG Capital, L.P.
3.97M
10.54%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
3.79M
10.08%
-519.05K
-12.03%
Dec 31, 2025
Longitude Capital Management Co., LLC
2.48M
6.58%
+2.48M
--
Oct 16, 2024
Global Value Investment Portfolio Management Pte. Ltd.
2.37M
6.29%
--
--
Dec 31, 2024
Red Tree Management, LLC
2.21M
5.86%
--
--
Dec 31, 2025
Parvizi (Josef)
2.09M
5.55%
+6.62K
+0.32%
Apr 11, 2025
BlackRock Institutional Trust Company, N.A.
1.63M
4.33%
+112.85K
+7.44%
Dec 31, 2025
Chao (Xingjuan)
1.07M
2.84%
+41.63K
+4.05%
Mar 25, 2026
KCM Capital Inc
1.00M
2.66%
+1.00M
--
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
iShares Neuroscience and Healthcare ETF
0.57%
Hypatia Women CEO ETF
0.5%
Fidelity Fundamental Small-Mid Cap ETF
0.1%
iShares Micro-Cap ETF
0.06%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 Growth ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Mehr Anzeigen
iShares Neuroscience and Healthcare ETF
Anteil0.57%
Hypatia Women CEO ETF
Anteil0.5%
Fidelity Fundamental Small-Mid Cap ETF
Anteil0.1%
iShares Micro-Cap ETF
Anteil0.06%
ProShares Hedge Replication ETF
Anteil0.02%
iShares Russell 2000 Growth ETF
Anteil0.02%
ProShares UltraPro Russell2000
Anteil0.01%
iShares Russell 2000 ETF
Anteil0.01%
Schwab U.S. Small-Cap ETF
Anteil0.01%
Proshares Ultra Russell 2000
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI